home.social

#jnj — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #jnj, aggregated by home.social.

  1. Johnson & Johnson (JNJ) 💰
    Kurs: ca. 235 $ ⇒ Ziel: 290 $+ 🎯

    Warum Potenzial? 📈

    🌍 Führend in Pharma & Medizintechnik
    🧪 Starke Pipeline (Immunologie, Onkologie)
    🏥 Mehr OPs & neue Produkte treiben Wachstum
    🧴 Nach Abspaltung stärker fokussiert
    💵 Dividende ~2,8 % (defensiv)

    📊 Analysten sehen >290 $ bei stabilem Gesundheitssektor

    #Aktien #Gesundheit #Dividende #JNJ

  2. For example, I know @[email protected] will probably like this, but @[email protected] has an entire landing page dedicated to #$JNJ, which would allow me to check whether the company is facing particular lawsuits, or trace particular product/ regulatory announcements to stock market performance

    Johnson & Johnson Archives

  3. Johnson (JNJ)

    #Tradingan - #Grafik #harga #saham #Johnson (JNJ) hari ini untuk membantu #analisa #pasar sebelum memulai #investasi dan #trading saham Johnson #JNJ. Johnson & Johnson (JNJ) adalah #salah satu #perusahaan #farmasi dan #perawatan #kesehatan #terbesar di dunia, dengan #portofolio produk yang mencakup #obat-obatan, #peralatan medis, dan produk perawatan #konsumen. Berikut adalah sejarah lengkap perusahaan ini, dari pendiriannya hingga menjadi pemimpin…

    tradingan.com/johnson

  4. DATE: January 27, 2025 at 08:30AM
    SOURCE: BioWorld MedTech

    Direct article link at end of text block below.

    PFA update: @AbbottNews to launch in EU, @JNJNews hold indefinite

    t.co/Qv3xPNJyQu

    #medtech #JNJ #Abbott #BostonScientific @BostonSci #Medtronic #PFA

    Here are any URLs found in the article text:

    t.co/Qv3xPNJyQu

    #medtech

    Articles can be found by scrolling down the page at bioworld.com/topics/85-bioworl .

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org
    .
    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
    .
    Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com
    .
    EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
    subscribe-article-digests.clin
    .
    READ ONLINE: read-the-rss-mega-archive.clin
    .
    It's primitive... but it works... mostly...
    .
    -------------------------------------------------

    #healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech

  5. DATE: January 27, 2025 at 08:30AM
    SOURCE: BioWorld MedTech

    Direct article link at end of text block below.

    PFA update: @AbbottNews to launch in EU, @JNJNews hold indefinite

    t.co/Qv3xPNJyQu

    #medtech #JNJ #Abbott #BostonScientific @BostonSci #Medtronic #PFA

    Here are any URLs found in the article text:

    t.co/Qv3xPNJyQu

    #medtech

    Articles can be found by scrolling down the page at bioworld.com/topics/85-bioworl .

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org
    .
    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
    .
    Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com
    .
    EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
    subscribe-article-digests.clin
    .
    READ ONLINE: read-the-rss-mega-archive.clin
    .
    It's primitive... but it works... mostly...
    .
    -------------------------------------------------

    #healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech

  6. DATE: January 27, 2025 at 08:30AM
    SOURCE: BioWorld MedTech

    Direct article link at end of text block below.

    PFA update: @AbbottNews to launch in EU, @JNJNews hold indefinite

    t.co/Qv3xPNJyQu

    #medtech #JNJ #Abbott #BostonScientific @BostonSci #Medtronic #PFA

    Here are any URLs found in the article text:

    t.co/Qv3xPNJyQu

    #medtech

    Articles can be found by scrolling down the page at bioworld.com/topics/85-bioworl .

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org
    .
    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
    .
    Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com
    .
    EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
    subscribe-article-digests.clin
    .
    READ ONLINE: read-the-rss-mega-archive.clin
    .
    It's primitive... but it works... mostly...
    .
    -------------------------------------------------

    #healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech

  7. DATE: January 27, 2025 at 08:30AM
    SOURCE: BioWorld MedTech

    Direct article link at end of text block below.

    PFA update: @AbbottNews to launch in EU, @JNJNews hold indefinite

    t.co/Qv3xPNJyQu

    #medtech #JNJ #Abbott #BostonScientific @BostonSci #Medtronic #PFA

    Here are any URLs found in the article text:

    t.co/Qv3xPNJyQu

    #medtech

    Articles can be found by scrolling down the page at bioworld.com/topics/85-bioworl .

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org
    .
    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
    .
    Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com
    .
    EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
    subscribe-article-digests.clin
    .
    READ ONLINE: read-the-rss-mega-archive.clin
    .
    It's primitive... but it works... mostly...
    .
    -------------------------------------------------

    #healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech

  8. DATE: January 24, 2025 at 06:30PM
    SOURCE: BioWorld MedTech

    Direct article link at end of text block below.

    PFA update: @AbbottNews to launch in EU, @JNJNews hold indefinite

    t.co/Qv3xPNJyQu

    #medtech #JNJ #Abbott #BostonScientific @BostonSci #Medtronic #PFA

    Here are any URLs found in the article text:

    t.co/Qv3xPNJyQu

    #medtech

    Articles can be found by scrolling down the page at bioworld.com/topics/85-bioworl .

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org
    .
    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
    .
    Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com
    .
    EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
    subscribe-article-digests.clin
    .
    READ ONLINE: read-the-rss-mega-archive.clin
    .
    It's primitive... but it works... mostly...
    .
    -------------------------------------------------

    #healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech

  9. DATE: January 24, 2025 at 06:30PM
    SOURCE: BioWorld MedTech

    Direct article link at end of text block below.

    PFA update: @AbbottNews to launch in EU, @JNJNews hold indefinite

    t.co/Qv3xPNJyQu

    #medtech #JNJ #Abbott #BostonScientific @BostonSci #Medtronic #PFA

    Here are any URLs found in the article text:

    t.co/Qv3xPNJyQu

    #medtech

    Articles can be found by scrolling down the page at bioworld.com/topics/85-bioworl .

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org
    .
    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
    .
    Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com
    .
    EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
    subscribe-article-digests.clin
    .
    READ ONLINE: read-the-rss-mega-archive.clin
    .
    It's primitive... but it works... mostly...
    .
    -------------------------------------------------

    #healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech

  10. DATE: January 24, 2025 at 06:30PM
    SOURCE: BioWorld MedTech

    Direct article link at end of text block below.

    PFA update: @AbbottNews to launch in EU, @JNJNews hold indefinite

    t.co/Qv3xPNJyQu

    #medtech #JNJ #Abbott #BostonScientific @BostonSci #Medtronic #PFA

    Here are any URLs found in the article text:

    t.co/Qv3xPNJyQu

    #medtech

    Articles can be found by scrolling down the page at bioworld.com/topics/85-bioworl .

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org
    .
    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
    .
    Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com
    .
    EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
    subscribe-article-digests.clin
    .
    READ ONLINE: read-the-rss-mega-archive.clin
    .
    It's primitive... but it works... mostly...
    .
    -------------------------------------------------

    #healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech

  11. DATE: January 24, 2025 at 06:30PM
    SOURCE: BioWorld MedTech

    Direct article link at end of text block below.

    PFA update: @AbbottNews to launch in EU, @JNJNews hold indefinite

    t.co/Qv3xPNJyQu

    #medtech #JNJ #Abbott #BostonScientific @BostonSci #Medtronic #PFA

    Here are any URLs found in the article text:

    t.co/Qv3xPNJyQu

    #medtech

    Articles can be found by scrolling down the page at bioworld.com/topics/85-bioworl .

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org
    .
    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
    .
    Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com
    .
    EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
    subscribe-article-digests.clin
    .
    READ ONLINE: read-the-rss-mega-archive.clin
    .
    It's primitive... but it works... mostly...
    .
    -------------------------------------------------

    #healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech

  12. Merck claims late-stage study success for RSV antibody  — Novo Nordisk's Wegovy gets UK approval for lowering heart risks — J&J vets burst into biotech with $165M Third Arc series A —bit.ly/w28kSd #rsv #merck #novonordisk #uk #wegovy #funding #jnj #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  13. Merck claims late-stage study success for RSV antibody  — Novo Nordisk's Wegovy gets UK approval for lowering heart risks — J&J vets burst into biotech with $165M Third Arc series A —bit.ly/w28kSd #rsv #merck #novonordisk #uk #wegovy #funding #jnj #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  14. Merck claims late-stage study success for RSV antibody  — Novo Nordisk's Wegovy gets UK approval for lowering heart risks — J&J vets burst into biotech with $165M Third Arc series A —bit.ly/w28kSd #rsv #merck #novonordisk #uk #wegovy #funding #jnj #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  15. Merck claims late-stage study success for RSV antibody  — Novo Nordisk's Wegovy gets UK approval for lowering heart risks — J&J vets burst into biotech with $165M Third Arc series A —bit.ly/w28kSd #rsv #merck #novonordisk #uk #wegovy #funding #jnj #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  16. Sure, it's good that they pulled Johnson & Johnson baby powder from the market.

    But it's the only household substance I found that completely confounded and deterred every type of ant in every part of the US.

    And yes, I tried all the spices, and peppermint oil. None were as effective. The J&J perfumed talc was much harsher to all the ants, and they really didn't like walking on it.

    #ants #jnj #babypowder

  17. Sure, it's good that they pulled Johnson & Johnson baby powder from the market.

    But it's the only household substance I found that completely confounded and deterred every type of ant in every part of the US.

    And yes, I tried all the spices, and peppermint oil. None were as effective. The J&J perfumed talc was much harsher to all the ants, and they really didn't like walking on it.

    #ants #jnj #babypowder

  18. Sure, it's good that they pulled Johnson & Johnson baby powder from the market.

    But it's the only household substance I found that completely confounded and deterred every type of ant in every part of the US.

    And yes, I tried all the spices, and peppermint oil. None were as effective. The J&J perfumed talc was much harsher to all the ants, and they really didn't like walking on it.

  19. Sure, it's good that they pulled Johnson & Johnson baby powder from the market.

    But it's the only household substance I found that completely confounded and deterred every type of ant in every part of the US.

    And yes, I tried all the spices, and peppermint oil. None were as effective. The J&J perfumed talc was much harsher to all the ants, and they really didn't like walking on it.

    #ants #jnj #babypowder

  20. Sure, it's good that they pulled Johnson & Johnson baby powder from the market.

    But it's the only household substance I found that completely confounded and deterred every type of ant in every part of the US.

    And yes, I tried all the spices, and peppermint oil. None were as effective. The J&J perfumed talc was much harsher to all the ants, and they really didn't like walking on it.

    #ants #jnj #babypowder

  21. Johnson & Johnson beats estimates with Q2 EPS at $2.82 (forecast: $2.72) and revenue at $22.45B (forecast: $22.34B). #JohnsonAndJohnson #Earnings #JNJ

  22. Johnson & Johnson beats estimates with Q2 EPS at $2.82 (forecast: $2.72) and revenue at $22.45B (forecast: $22.34B). #JohnsonAndJohnson #Earnings #JNJ

  23. Johnson & Johnson beats estimates with Q2 EPS at $2.82 (forecast: $2.72) and revenue at $22.45B (forecast: $22.34B). #JohnsonAndJohnson #Earnings #JNJ

  24. Moderna receives $176 million from BARDA for mRNA influenza vaccines—J&J, Legend's Carvykti shows CAR-T can extend lives in multiple myeloma —The IRA will lower U.S. drug spending, CMS finds — but not for awhile—bit.ly/w28kSd #moderna #barda #mrna #vaccines #flu #jnj #multiplemyeloma #ira #drugspending #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  25. Moderna receives $176 million from BARDA for mRNA influenza vaccines—J&J, Legend's Carvykti shows CAR-T can extend lives in multiple myeloma —The IRA will lower U.S. drug spending, CMS finds — but not for awhile—bit.ly/w28kSd #moderna #barda #mrna #vaccines #flu #jnj #multiplemyeloma #ira #drugspending #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  26. Moderna receives $176 million from BARDA for mRNA influenza vaccines—J&J, Legend's Carvykti shows CAR-T can extend lives in multiple myeloma —The IRA will lower U.S. drug spending, CMS finds — but not for awhile—bit.ly/w28kSd #moderna #barda #mrna #vaccines #flu #jnj #multiplemyeloma #ira #drugspending #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  27. Moderna receives $176 million from BARDA for mRNA influenza vaccines—J&J, Legend's Carvykti shows CAR-T can extend lives in multiple myeloma —The IRA will lower U.S. drug spending, CMS finds — but not for awhile—bit.ly/w28kSd #moderna #barda #mrna #vaccines #flu #jnj #multiplemyeloma #ira #drugspending #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  28. Merck’s potential $3B EyeBio acquisition puts drugmaker back in ophthalmology—J&J's depression treatment succeeds in late-stage study — AstraZeneca throws its hat into the oral PCSK9 ring--bit.ly/w28kSd #merck #mergersandacquistions #clinicaltrials #ophthalmology #depression #jnj #astrazeneca #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  29. Merck’s potential $3B EyeBio acquisition puts drugmaker back in ophthalmology—J&J's depression treatment succeeds in late-stage study — AstraZeneca throws its hat into the oral PCSK9 ring--bit.ly/w28kSd #merck #mergersandacquistions #clinicaltrials #ophthalmology #depression #jnj #astrazeneca #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  30. Merck’s potential $3B EyeBio acquisition puts drugmaker back in ophthalmology—J&J's depression treatment succeeds in late-stage study — AstraZeneca throws its hat into the oral PCSK9 ring--bit.ly/w28kSd #merck #mergersandacquistions #clinicaltrials #ophthalmology #depression #jnj #astrazeneca #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  31. Merck’s potential $3B EyeBio acquisition puts drugmaker back in ophthalmology—J&J's depression treatment succeeds in late-stage study — AstraZeneca throws its hat into the oral PCSK9 ring--bit.ly/w28kSd #merck #mergersandacquistions #clinicaltrials #ophthalmology #depression #jnj #astrazeneca #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  32. J&J scoops up another atopic dermatitis antibody in $1.25B Numab rights deal—Health and biotech startups now get the majority of US Series A funding — Clinical-stage cancer biotech Actuate latest to eye summer IPO --bit.ly/w28kSd #jnj #atopicdermatitis #eczema #funding #ipos #oncology #cancer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  33. J&J scoops up another atopic dermatitis antibody in $1.25B Numab rights deal—Health and biotech startups now get the majority of US Series A funding — Clinical-stage cancer biotech Actuate latest to eye summer IPO --bit.ly/w28kSd #jnj #atopicdermatitis #eczema #funding #ipos #oncology #cancer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  34. J&J scoops up another atopic dermatitis antibody in $1.25B Numab rights deal—Health and biotech startups now get the majority of US Series A funding — Clinical-stage cancer biotech Actuate latest to eye summer IPO --bit.ly/w28kSd #jnj #atopicdermatitis #eczema #funding #ipos #oncology #cancer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  35. J&J scoops up another atopic dermatitis antibody in $1.25B Numab rights deal—Health and biotech startups now get the majority of US Series A funding — Clinical-stage cancer biotech Actuate latest to eye summer IPO --bit.ly/w28kSd #jnj #atopicdermatitis #eczema #funding #ipos #oncology #cancer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  36. J&J to buy Proteologix and its dual-targeting antibody drugs for $850M—Biogen walks away from Ionis-partnered ALS, Angelman prospects after peek at clinical data —FDA approves expanded use of Bristol Myers' cancer cell therapy --bit.ly/w28kSd #jnj #biogen #als #celltherapy #fda #bristolmyerssquibb #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  37. J&J to buy Proteologix and its dual-targeting antibody drugs for $850M—Biogen walks away from Ionis-partnered ALS, Angelman prospects after peek at clinical data —FDA approves expanded use of Bristol Myers' cancer cell therapy --bit.ly/w28kSd #jnj #biogen #als #celltherapy #fda #bristolmyerssquibb #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  38. J&J to buy Proteologix and its dual-targeting antibody drugs for $850M—Biogen walks away from Ionis-partnered ALS, Angelman prospects after peek at clinical data —FDA approves expanded use of Bristol Myers' cancer cell therapy --bit.ly/w28kSd #jnj #biogen #als #celltherapy #fda #bristolmyerssquibb #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma